← Open Payments lookup

MICHAEL JOHN SOLON: Open Payments

NPI 1295478337 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,524 in 148 payments from 15 companies in 2025. Trend: 2023 $1,282 · 2024 $3,928 · 2025 $4,524

Food & beverage: $4,524
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.14$670
Alkermes, Inc.20$642
Teva Pharmaceuticals USA, Inc.21$595
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$561
ABBVIE INC.20$462
Supernus Pharmaceuticals, Inc.24$440
E.R. Squibb & Sons, L.L.C.7$290
Collegium Pharmaceutical, Inc.8$225
Corium, LLC10$173
Melinta Therapeutics, LLC1$125

Products named: CAPLYTA, REXULTI, VRAYLAR, Qelbree, ARISTADA, UZEDY, COBENFY, LYBALVI.

Industry payments across TX — which companies pay providers there.